Search results for "K-Bio"

South Korea Proposes Steep Hikes in Drug Approval Fees, With Cell and Gene Therapy Costs to Reach 20.71 Million Won

South Korea Proposes Steep Hikes in Drug Approval Fees, With Cell and Gene Therapy Costs to Reach 20.71 Million Won

South Korea’s Ministry of Food and Drug Safety issued notices of proposed rulemaking and administrative changes on Nov.
Red Patches on the Skin: Diagnostic Model Distinguishes Bowen’s Disease From Precancerous Lesions With 95% Accuracy

Red Patches on the Skin: Diagnostic Model Distinguishes Bowen’s Disease From Precancerous Lesions With 95% Accuracy

If a red patch appears on the skin and begins to scale, could it be skin cancer? Distinguishing early-stage skin cancer from precancerous lesions can...
Asan Medical Center Introduces Korea’s First Transperineal Robotic Prostate Biopsy System

Asan Medical Center Introduces Korea’s First Transperineal Robotic Prostate Biopsy System

In prostate cancer diagnostics, minimizing procedural infection risks is as vital as accurately sampling suspicious...
Beyond Facial Wrinkles: 5 Internal Factors Accelerating Biological Aging

Beyond Facial Wrinkles: 5 Internal Factors Accelerating Biological Aging

Aging is an inevitable biological process, but the rate at which it occurs is largely within individual control.
MS Bio Pursues IPO to Fuel Expansion into Amniotic Lenses, Aesthetics, and Global Markets

MS Bio Pursues IPO to Fuel Expansion into Amniotic Lenses, Aesthetics, and Global Markets

MS Bio, a specialized manufacturer of human tissue graft materials and medical devices, is leveraging its upcoming...
Pediatric Crohn’s: Switching Biologics Yields Similar Remission Rates Despite Lower Blood Drug Levels

Pediatric Crohn’s: Switching Biologics Yields Similar Remission Rates Despite Lower Blood Drug Levels

Pediatric and adolescent Crohn’s disease patients who switch to infliximab after losing responsiveness to adalimumab...
Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells

Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells

South Korean researchers have developed a novel anticancer approach capable of selectively turning off specific...
Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion is stepping up efforts to identify and foster promising biotech startups in Japan.
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the...
Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51

Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51

Celltrion announced on August 24 that it has submitted a marketing authorization application to South Korea’s Ministry...